What is the recommended dosing of prazosin (Prazosin) for patients (pts) with post-traumatic stress disorder (PTSD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prazosin Dosing for PTSD

For patients with PTSD-associated nightmares, prazosin should be initiated at 1 mg at bedtime and gradually titrated by 1-2 mg every 3-7 days until effective, with typical maintenance doses ranging from 3-15 mg daily depending on patient population (lower doses for civilians, higher doses for veterans). 1

Initial Dosing and Titration

  • Starting dose: 1 mg at bedtime 2, 1
  • Titration schedule: Increase by 1-2 mg every 3-7 days based on response and tolerability 1
  • Monitoring: Check blood pressure after first dose and during dose increases to monitor for orthostatic hypotension 1

Population-Specific Dosing Considerations

Military Veterans

  • Typical effective dose range: 9.5-15.6 mg/day 2, 1
  • Maximum studied dose: Up to 20 mg daily in divided doses 3
  • Some veterans may require higher doses (up to 15-20 mg) for adequate symptom control 2

Civilian Trauma Survivors

  • Typical effective dose range: 3-6 mg/day 1
  • Mean effective dose in civilian studies: 3.1 mg ± 1.3 mg 2

Gender Differences

  • Women may respond to lower doses (average 7.0 mg) compared to men (average 15.6 mg) 2, 1

Dosing Schedule Options

  1. Standard approach: Once daily dosing at bedtime for nightmare-predominant symptoms 2
  2. Divided dosing: For patients with both nightmares and daytime symptoms:
    • Consider twice or three times daily dosing 4
    • Morning dose may help with daytime flashbacks 4

Monitoring for Efficacy

  • Evaluate nightmare frequency and intensity after 2-4 weeks at each dose level
  • Use standardized measures like CAPS "recurrent distressing dreams" item 1
  • Target is ≥50% reduction in nightmare frequency/intensity 2

Side Effect Management

  • Primary concern: Orthostatic hypotension, especially during initiation and dose increases 1
  • Common side effects: Dizziness, drowsiness, headache 1, 5
  • First-dose effect: Consider administering initial dose at bedtime to minimize orthostatic symptoms 5
  • Caution with concurrent PDE-5 inhibitors due to additive hypotensive effects 3

Treatment Algorithm

  1. Initial phase: Start with 1 mg at bedtime
  2. Titration phase: Increase by 1-2 mg every 3-7 days
  3. Target dose:
    • Civilians: 3-6 mg/day
    • Veterans: 9-15 mg/day
  4. Inadequate response: If partial response after 4-6 weeks at maximum tolerated dose:
    • Consider further dose increases up to 20 mg daily (some case reports show benefit up to 30-45 mg in treatment-resistant cases) 6
    • Consider adding adjunctive therapy (e.g., Image Rehearsal Therapy) 1

Important Clinical Considerations

  • Prazosin has Level A evidence for PTSD-associated nightmares 2, 1
  • Response may occur within 1-2 weeks of reaching effective dose 5
  • Patients taking SSRIs may show decreased response to prazosin 2
  • Some patients may require long-term maintenance therapy, as symptoms often return upon discontinuation 2, 7

Prazosin offers a well-tolerated and effective approach for managing PTSD-related nightmares, with strong evidence supporting its use as first-line pharmacotherapy for this specific symptom.

References

Guideline

Treatment of PTSD-Associated Nightmares

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prazosin for treatment of nightmares related to posttraumatic stress disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Research

High-dose prazosin for the treatment of post-traumatic stress disorder.

Therapeutic advances in psychopharmacology, 2014

Research

Prazosin in the treatment of PTSD.

Journal of psychiatric practice, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.